Skip to content

Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease

Is the Short Physical Performance Battery a Useful Outcome Measure in Patients With Chronic Obstructive Pulmonary Disease ?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01515709
Enrollment
445
Registered
2012-01-24
Start date
2011-04-30
Completion date
2018-09-30
Last updated
2018-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchitis, Chronic, Disease Progression, Lung Diseases, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema

Keywords

Cohort Studies, Longitudinal Studies

Brief summary

Patients with Chronic Obstructive Lung Disease (COPD) often develop muscle problems, particularly in their legs which makes them more limited in what they can do. The Short Physical Performance Battery (SPPB) is a simple test of standing balance, usual walking speed and ability to stand from a chair. The SPPB may be a useful measure to predict leg function. This study aims to evaluate whether the SPPB is comparable with current exercise tests used in COPD patients, and whether it is useful in predicting disability, death and health resource usage over time.

Interventions

None listed

Sponsors

Medical Research Council
CollaboratorOTHER_GOV
Royal Brompton & Harefield NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosis of COPD

Exclusion criteria

* Any patient in whom mobility and lower limb function have been significantly affected by a neuromuscular cause (eg. motor neurone disease), severe peripheral vascular disease or amputation * Any patient whom is deemed unsafe to exercise * Patients unable to complete the SPPB, walking tests and leg strength assessments.

Design outcomes

Primary

MeasureTime frame
Mortality rate36 months

Secondary

MeasureTime frame
Hospitalisation rate36 months
Healthcare resource usage36 months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026